Cause of death and predictors of all-cause mortality in anticoagulated patients with nonvalvular atrial fibrillation: Data from ROCKET AF

• Main Authors: Pokorney, S.D, Piccini, J.P, Stevens, S.R
• Other Authors: MEDICINE
• Format: Article
• Published: 2020
• Subjects: creatinine; rivaroxaban; warfarin; anticoagulant agent; blood clotting factor 10a inhibitor; age; aged; anticoagulant therapy; Article; atrial fibrillation; cardiovascular disease; cardiovascular mortality; cause of death; cerebrovascular accident; CHADS2 score; chronic obstructive lung disease; creatinine clearance; diabetes mellitus; embolism; female; heart failure; human; major clinical study; male; mortality; mortality rate; nonvalvular atrial fibrillation; peripheral vascular disease; priority journal; randomized controlled trial (topic); sex difference; blood; clinical trial; comorbidity; comparative study; complication; controlled study; double blind procedure; drug administration; intention to treat analysis; Kaplan Meier method; multicenter study; multivariate analysis; oral drug administration; proportional hazards model; randomized controlled trial; risk assessment; risk factor; Stroke; time factor; treatment outcome; very elderly; Administration, Oral; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cause of Death; Comorbidity; Double-Blind Method; Drug Administration Schedule; Factor Xa Inhibitors; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Multivariate Analysis; Proportional Hazards Models; Risk Assessment; Risk Factors; Rivaroxaban; Sex Factors; Time Factors; Treatment Outcome; Warfarin
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/180349
• Institution: National University of Singapore

10.1161/JAHA.115.002197